Cargando…
Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs
SIMPLE SUMMARY: Heterogeneity is the characteristic of breast tumors, making it difficult to understand the molecular mechanism. Alteration of gene expression in the primary tumor versus the metastatic lesion remains challenging for getting any specific targeted therapy. To better understand how gen...
Autores principales: | Maiti, Aparna, Okano, Ichiro, Oshi, Masanori, Okano, Maiko, Tian, Wanqing, Kawaguchi, Tsutomu, Katsuta, Eriko, Takabe, Kazuaki, Yan, Li, Patnaik, Santosh K., Hait, Nitai C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199412/ https://www.ncbi.nlm.nih.gov/pubmed/34072157 http://dx.doi.org/10.3390/cancers13112641 |
Ejemplares similares
-
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival
por: Okano, Maiko, et al.
Publicado: (2019) -
Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells
por: Maiti, Aparna, et al.
Publicado: (2019) -
Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
por: Oshi, Masanori, et al.
Publicado: (2020) -
Autophagy-mediated tumor cell survival and progression of breast cancer metastasis to the brain
por: Maiti, Aparna, et al.
Publicado: (2021) -
A Novel 4-gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)